Ascorbic acid in Charcot—Marie—Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial The Lancet Neurology, 04/05/2011

Pareyson D et al. – Ascorbic acid supplementation had no significant effect on neuropathy compared with placebo after 2 years, suggesting that no evidence is available to support treatment with ascorbic acid in adults with Charcot—Marie—Tooth disease type 1AV

Read this article on The Lancet Neurology



 

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here